Abstract and Introduction Abstract. Polycystic ovary syndrome (PCOS) and Type 2 diabetes mellitus (T2D) are both obesity-related conditions that share epidemiological and pathophysiological factors.

A subset of women with polycystic ovary syndrome ... Obesity is often associated with PCOS, and its presence may be responsible for alterations of the hypothalamic–pituitary–adrenal axis.

A new study published in the International Journal of Molecular Sciences showed that hyperprolactinemia may act as a ...

As Wegovy ushers in a new wave of weight-loss drugs to tackle India's growing obesity crisis, Dr. Rishma Pai sheds light on ...

Supplements such as curcumin, vitamin D, inositol, berberine, and chasteberry may help improve PCOS symptoms, especially when ...

Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...

Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...

A low-carbohydrate (low-carb) diet restricts things like pasta, bread, and sugary foods. Here’s why you might consider the ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a ...